NASDAQ: KIDSOrthopediatrics Corp Stock
$29.94-1.26 (-4.04%)
Updated Apr 25, 2024
KIDS Price
$29.94
Fair Value Price
$31.63
Market Cap
$705.07M
52 Week Low
$23.10
52 Week High
$53.50
P/E
-32.54x
P/B
1.87x
P/S
4.96x
PEG
N/A
Dividend Yield
N/A
Revenue
$148.73M
Earnings
-$20.97M
Gross Margin
74.8%
Operating Margin
-14.46%
Profit Margin
-14.1%
Debt to Equity
0.16
Operating Cash Flow
-$27M
Beta
1.08
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
KIDS Overview
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KIDS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KIDS ($29.94) is undervalued by 5.34% relative to our estimate of its Fair Value price of $31.63 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
KIDS ($29.94) is not significantly undervalued (5.34%) relative to our estimate of its Fair Value price of $31.63 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
KIDS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more KIDS due diligence checks available for Premium users.
Be the first to know about important KIDS news, forecast changes, insider trades & much more!
KIDS News
Valuation
KIDS fair value
Fair Value of KIDS stock based on Discounted Cash Flow (DCF)
Price
$29.94
Fair Value
$31.63
Undervalued by
5.34%
KIDS ($29.94) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
KIDS ($29.94) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
KIDS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
KIDS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-32.54x
Industry
29.73x
Market
40.97x
KIDS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.87x
Industry
3.71x
KIDS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KIDS's financial health
Profit margin
Revenue
$37.6M
Net Income
-$6.7M
Profit Margin
-17.8%
KIDS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
KIDS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$438.7M
Liabilities
$61.7M
Debt to equity
0.16
KIDS's short-term assets ($226.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KIDS's short-term assets ($226.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KIDS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
KIDS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$7.5M
Investing
$17.9M
Financing
$9.4M
KIDS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
KIDS vs Medical Device Stocks
Orthopediatrics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.